Mark A. Arredondo

1.2k total citations
19 papers, 1.0k citations indexed

About

Mark A. Arredondo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark A. Arredondo has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark A. Arredondo's work include Cancer therapeutics and mechanisms (3 papers), Breast Lesions and Carcinomas (3 papers) and MRI in cancer diagnosis (2 papers). Mark A. Arredondo is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Breast Lesions and Carcinomas (3 papers) and MRI in cancer diagnosis (2 papers). Mark A. Arredondo collaborates with scholars based in United States. Mark A. Arredondo's co-authors include Paul C. Stomper, Janet S. Winston, Stephen B. Edge, Leslie E. Blumenson, Donald Klippenstein, Steven D. Herman, John F. Gibbs, Dominick Lamonica, William E. Carson and Paul J. Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Radiology.

In The Last Decade

Mark A. Arredondo

19 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Arredondo United States 12 379 377 362 351 186 19 1.0k
Dieter Lampe Germany 14 412 1.1× 425 1.1× 550 1.5× 333 0.9× 75 0.4× 32 1.1k
Martín Velasco Spain 14 209 0.6× 316 0.8× 423 1.2× 389 1.1× 111 0.6× 24 816
Corrado Tinterri Italy 18 487 1.3× 318 0.8× 621 1.7× 256 0.7× 189 1.0× 79 1.1k
Svjetlana Mohrmann Germany 16 588 1.6× 160 0.4× 441 1.2× 222 0.6× 236 1.3× 63 1.1k
L. Assersohn United Kingdom 15 513 1.4× 192 0.5× 430 1.2× 230 0.7× 243 1.3× 21 1.2k
Vania Vezzosi Italy 25 548 1.4× 643 1.7× 746 2.1× 187 0.5× 118 0.6× 56 1.4k
Samuele Massarut Italy 21 558 1.5× 308 0.8× 794 2.2× 316 0.9× 238 1.3× 67 1.5k
Youlia Kirova France 18 466 1.2× 241 0.6× 691 1.9× 391 1.1× 307 1.7× 50 1.3k
Rubina Manuela Trimboli Italy 19 236 0.6× 279 0.7× 314 0.9× 589 1.7× 307 1.7× 38 1.1k
Ciqiu Yang China 14 238 0.6× 141 0.4× 298 0.8× 222 0.6× 121 0.7× 58 663

Countries citing papers authored by Mark A. Arredondo

Since Specialization
Citations

This map shows the geographic impact of Mark A. Arredondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Arredondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Arredondo more than expected).

Fields of papers citing papers by Mark A. Arredondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Arredondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Arredondo. The network helps show where Mark A. Arredondo may publish in the future.

Co-authorship network of co-authors of Mark A. Arredondo

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Arredondo. A scholar is included among the top collaborators of Mark A. Arredondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Arredondo. Mark A. Arredondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Arredondo, Mark A., et al.. (2019). Gold nanoparticle uptake is enhanced by estradiol in MCF-7 breast cancer cells. SHILAP Revista de lepidopterología. 2 indexed citations
2.
Sakakibara, Takashi, Yan Xu, Harvey L. Bumpers, et al.. (2006). Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.. PubMed. 2(5). 291–300. 20 indexed citations
3.
Arredondo, Mark A., Daniel R. Kollmorgen, John F. Gibbs, et al.. (1998). Sentinel node biopsy in breast cancer. Annals of Surgical Oncology. 5(2). 126–130. 219 indexed citations
4.
Arredondo, Mark A., et al.. (1998). Sarcoma of the breast: implications of the extent of local therapy.. PubMed. 64(11). 1059–61. 27 indexed citations
5.
Stomper, Paul C., Janet S. Winston, Steven D. Herman, et al.. (1997). Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Research and Treatment. 45(1). 39–46. 103 indexed citations
6.
Cuenca, Rosa, et al.. (1996). Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen use. Cancer. 77(10). 2058–2063. 4 indexed citations
7.
Cuenca, Rosa, et al.. (1996). Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen use. Cancer. 77(10). 2058–2063. 30 indexed citations
8.
Stomper, Paul C., et al.. (1996). Analysis of parenchymal density on mammograms in 1353 women 25-79 years old.. American Journal of Roentgenology. 167(5). 1261–1265. 208 indexed citations
9.
Stomper, Paul C., Remedios Penetrante, Stephen B. Edge, et al.. (1996). Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage. Breast Cancer Research and Treatment. 37(3). 229–236. 11 indexed citations
10.
Matsui, Seiichi, et al.. (1996). DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.. PubMed. 56(20). 4715–23. 51 indexed citations
11.
Stomper, Paul C., Steven D. Herman, Donald Klippenstein, et al.. (1995). Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.. Radiology. 197(2). 387–395. 184 indexed citations
12.
Tóth, Károly, Mary M. Vaughan, Harry K. Slocum, et al.. (1994). New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.. PubMed. 144(2). 227–36. 45 indexed citations
13.
Arredondo, Mark A., et al.. (1994). Down-regulation of c-myc gene expression with induction of high molecular weight DNA fragments by fluorodeoxyuridine. Biochemical Pharmacology. 48(2). 327–334. 6 indexed citations
14.
Nava, Hector & Mark A. Arredondo. (1993). Diagnosis of Gastric Cancer: Endoscopy, Imaging, and Tumor Markers. Surgical Oncology Clinics of North America. 2(3). 371–392. 3 indexed citations
15.
Yin, Ming, et al.. (1992). Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor.. PubMed. 52(21). 5900–5. 31 indexed citations
16.
Tóth, Károly, Mary M. Vaughan, Harry K. Slocum, et al.. (1992). Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomas.. PubMed. 140(5). 1009–16. 16 indexed citations
17.
Baciewicz, Frank A., et al.. (1991). Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin. Journal of Surgical Research. 50(2). 124–128. 29 indexed citations
18.
Arredondo, Mark A., et al.. (1990). Isolated perfusion of pancreas with mitomycin C. The American Journal of Surgery. 159(6). 569–574. 9 indexed citations
19.
Arredondo, Mark A., Neil R. Thomford, B. K. Chaudhuri, & P. K. Chaudhuri. (1989). Pharmacokinetics and tissue uptake of mitomycin C in isolated perfusion of pancreas. Journal of Surgical Research. 46(5). 445–449. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dieter Lampe Breakdown of academic impact, for papers by Martín Velasco Breakdown of academic impact, for papers by Corrado Tinterri Breakdown of academic impact, for papers by Svjetlana Mohrmann Breakdown of academic impact, for papers by L. Assersohn Breakdown of academic impact, for papers by Vania Vezzosi Breakdown of academic impact, for papers by Samuele Massarut Breakdown of academic impact, for papers by Youlia Kirova Breakdown of academic impact, for papers by Rubina Manuela Trimboli Breakdown of academic impact, for papers by Ciqiu Yang
Rankless by CCL
2026